"Charlotte Eye Ear Nose & Throat Associates, P.A. is the premier source for eye, ear, nose, and throat care throughout the Carolinas. Our award-winning medical staff is well trained in treating both common and complicated medical conditions. With more than 100 providers in nearly 20 locations, finding treatment for your eye, ear, nose, and throat needs has never been easier. Click on the selections in the menu bar to learn more about all the treatment CEENTA offers. Virtual visits can now be requested by calling 704.295.3003. Most ENT conditions and select eye conditions qualify for virtual visits."

During the past decade, Charlotte Eye, Ear, Nose and Throat Assoc., PA conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 43 clinical trials were completed, i.e. on average, 78.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 32 clinical trials were completed. i.e. 213.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" #1 sponsor was "Jaeb Center for Health Research" with 20 trials, followed by "Hoffmann-La Roche" with 15 trials sponsored, "Genentech, Inc." with 6 trials sponsored, "Aerie Pharmaceuticals" with 5 trials sponsored and "Allergan" with 5 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" #1 collaborator was "National Eye Institute (NEI)" with 21 trials as a collaborator, "Genentech, Inc." with 7 trials as a collaborator, "National Institutes of Health (NIH)" with 6 trials as a collaborator, "Regeneron Pharmaceuticals" with 5 trials as a collaborator and "Allergan" with 4 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" are "Diabetic Macular Edema" (19 trials), "Geographic Atrophy" (12 trials), "Diabetic Retinopathy" (11 trials), "Ocular Hypertension" (8 trials) and "Macular Degeneration" (7 trials). Many other conditions were trialed in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" in a lesser frequency.

Most popular intervention types in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" are "Drug" (86 trials), "Other" (22 trials), "Procedure" (10 trials), "Device" (8 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Sham Procedure" (10 trials), "Ranibizumab" (8 trials), "Faricimab" (6 trials) and "Aflibercept" (5 trials). Other intervention names were less common.

The vast majority of trials in "Charlotte Eye, Ear, Nose and Throat Assoc., PA" are 104 trials for "All" genders.

Currently, there are NaN active trials in "Charlotte Eye, Ear, Nose and Throat Assoc., PA". undefined are not yet recruiting, 1 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 78 completed trials in Charlotte Eye, Ear, Nose and Throat Assoc., PA, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Charlotte Eye, Ear, Nose and Throat Assoc., PA, 7 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".